According to the latest enforcement report by the US Food and Drug Administration (USFDA), Cipla's subsidiary in New Jersey is recalling 59,24 packs of Ipratropium Bromide and Albuterol Sulfate Inhalation Solution.

The reason for recalling the affected lots of Cipla products is “Short Fill”.

"There were complaints of underfilling of respules and a few drops of Liqui being observed in intact sachets," the US health regulator said.

The recalled drug is used to help control symptoms of lung diseases including asthma, chronic bronchitis and emphysema.

As reported by the USFDA, Glenmark is recalling 3,264 bottles of diltiazem hydrochloride extended-release capsules, which are used to treat high blood pressure.

The company's US-based arm, Glenmark Pharmaceuticals, initiated a nationwide recall of the drug due to "failed dissolution specifications".

Meanwhile, according to the US health regulator, drugmaker Lupine has recalled products from the US market due to manufacturing issues.

According to the latest enforcement report by USFDA, Lupine recalled 26,352 bottles of antibiotic drug Rifampin Capsules (300 mg) in the US market.